Coherus Biosciences

Develops and commercializes high-quality biosimilar therapeutics worldwide using advanced analytics.
Develops and commercializes high-quality biosimilar therapeutics worldwide using advanced analytics.

Sector

Life Sciences

Category

Therapeutics

Location

Redwood City, CA

Initial Investment

2014
Coherus Biosciences

Coherus Biosciences (NASDAQ: CHRS) is a biosimilar-focused, biologics platform company with the cutting-edge analytics, process science, and clinical and regulatory capabilities to develop and commercialize high-quality biosimilar therapeutics worldwide.